04/02/2025
3:13 PM | AdvisorShares Trust (Filed by)
InMed Pharmaceuticals (Subject)
| Form SCHEDULE 13G/A | |
02/14/2025
1:56 PM | InMed Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/13/2025
8:38 AM | InMed Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/12/2025
4:30 PM | InMed Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
02/03/2025
10:20 AM | InMed Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/03/2025
7:49 AM | HULL ANDREW (Reporting)
InMed Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/22/2025
9:18 AM | InMed Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/21/2025
9:54 AM | InMed Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/02/2025
10:46 AM | InMed Pharmaceuticals (Filer)
| Form 424B3 | |
01/01/2025
11:15 PM | InMed Pharmaceuticals (Filer)
| Form EFFECT | |
12/30/2024
11:16 AM | InMed Pharmaceuticals (Filer)
| Form S-1/A | |
Get the Latest News and Ratings for INM and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for InMed Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. |
12/23/2024
4:16 PM | InMed Pharmaceuticals (Filer)
| Form S-1
Registration statement under Securities Act of 1933 | |
12/23/2024
8:25 AM | InMed Pharmaceuticals (Issuer)
Lemerond Nicole (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/23/2024
8:26 AM | InMed Pharmaceuticals (Issuer)
Jagpal Netta (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/23/2024
8:28 AM | InMed Pharmaceuticals (Issuer)
Johnson Shane Aaron (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/23/2024
8:17 AM | HULL ANDREW (Reporting)
InMed Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/23/2024
8:18 AM | Baldasare Bryan T (Reporting)
InMed Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/23/2024
8:20 AM | ADAMS ERIC A (Reporting)
InMed Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/23/2024
8:21 AM | HSU ERIC C (Reporting)
InMed Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/23/2024
8:22 AM | Grove Janet P (Reporting)
InMed Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/23/2024
8:24 AM | InMed Pharmaceuticals (Issuer)
WOUDENBERG MICHAEL (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/20/2024
5:18 AM | InMed Pharmaceuticals (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
12/19/2024
10:55 AM | InMed Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/18/2024
7:05 AM | InMed Pharmaceuticals (Subject)
YA II PN, Ltd. (Filed by)
| Form SCHEDULE 13G | |
11/12/2024
12:44 PM | AdvisorShares Trust (Filed by)
InMed Pharmaceuticals (Subject)
| Form SC 13G | |
11/05/2024
8:08 AM | InMed Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/28/2024
3:50 PM | InMed Pharmaceuticals (Filer)
| Form DEF 14A | |
10/28/2024
3:00 PM | InMed Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/28/2024
2:25 PM | InMed Pharmaceuticals (Filer)
| Form DEFA14A | |
10/24/2024
2:57 PM | InMed Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/23/2024
11:28 AM | InMed Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/17/2024
5:30 AM | InMed Pharmaceuticals (Filer)
| Form 424B3 | |
09/30/2024
12:37 PM | InMed Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/26/2024
3:10 PM | InMed Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/21/2024
1:04 PM | InMed Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/20/2024
1:00 PM | InMed Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/30/2024
2:08 PM | InMed Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/27/2024
7:32 PM | InMed Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/11/2024
11:48 AM | InMed Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/28/2024
3:26 PM | HSU ERIC C (Reporting)
InMed Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/18/2024
12:30 PM | InMed Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
This almost killed Elon Musk (chilling details emerge) (Ad) Elon Musk's Near-Death Experience Sparks Dire Warning for Americans
After cheating death twice—once in a terrifying supercar crash with billionaire Peter Thiel, then from a deadly strain of malaria—Elon Musk emerged with a stark warning for Americans about looming financial dangers. Discover the little-known Trump IRS loophole that thousands are now using to safeguard their retirement from inflation and market turmoil—before it's too late. See why thousands of forward-thinking retirement savers are now requesting this FREE 2025 Wealth Pro |
04/16/2024
1:39 PM | InMed Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/05/2024
10:26 AM | InMed Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
